Navigation Links
eFoodSafety.com Selects Arcand & Madison as Public Relations Counsel and The Ruth Group as Investor Relations Counsel
Date:1/26/2009

SCOTTSDALE, Ariz., Jan. 26 /PRNewswire-FirstCall/ -- eFoodSafety.com, Inc. (OTC Bulletin Board: EFSF.OB), an emerging healthcare consumer products company with a portfolio of aesthetics, dermatology, environmental and nutraceutical products, today announced signing one year contracts with Arcand & Madison Public Relations and The Ruth Group (TRG).

Recently, eFoodSafety.com entered into a definitive agreement to merge with Freedom2 Holdings, Inc. The merger is on track to close on or before February 28, 2009.

"We are partnering with Arcand & Madison and TRG to ensure strong, ongoing communications," stated Martin Schmieg, current president and CEO of Freedom2, Inc. and future Chairman and CEO of eFoodSafety.com, Inc. "We expect that for the growing market of individuals looking for safer, more trustworthy health care alternatives, information from eFoodSafety will be welcome news."

Ms. Pat Arcand, Partner, Arcand & Madison, said, "Working with eFoodSafety is an opportunity to educate the public about the benefits of a new class of scientifically developed and tested consumer health care products."

Ms. Carol Ruth, President of The Ruth Group, said "We welcome the opportunity to demonstrate that eFoodSafety.com is a compelling investment opportunity in the growing healthcare market."

Both agencies have been retained for one year for a total cost of $120,000.

About eFoodSafety.com, Inc.

eFoodSafety is an emerging healthcare consumer products company with a portfolio of aesthetics, dermatology, environmental and nutraceutical products. The company's focus is on developing, licensing and commercialized healthcare products that address the health needs of consumers worldwide.

About Freedom2 Holdings, Inc.

Freedom2, Inc. is a diversified skin products technology company serving the fast-growing body art, aesthetic, cosmetic and skin therapy markets worldwide. It is the first company to engineer and patent a permanent, but more easily removable ink for tattoos and permanent cosmetics.

About Arcand & Madison Public Relations

Arcand & Madison Public Relations is a high-impact PR agency that helps clients communicate more effectively with their many diverse constituencies. Drawing upon over twenty years of high technology market PR experience and working with a wide network of dedicated professionals, Arcand and Madison is focused on building the community, relationships and awareness that's essential to helping clients reach their business goals. For more information, please visit http://www.am-pr.com.

About The Ruth Group

The Ruth Group (TRG) is a New York City-based full service investor relations and public relations agency providing top-tier counsel, communications strategies and capital markets advisory to emerging healthcare and technology companies. TRG's integrated, targeted outreach efforts leverage the agency's relationships with U.S. investors and media outlets to maximize the impact of positive milestones and enhance visibility for each client. For more information, please visit http://www.theruthgroup.com.

Safe Harbor for Public Companies

Statements contained in this release that are not strictly historical are "forward-looking statements." Such forward-looking statements are sometimes identified by words such as "intends," "anticipates," "believes," "expects," and "hopes." The forward-looking statements are made based on information available as of the date hereof, and the Company assumes no obligation to update such forward-looking statements. Editors and investors are cautioned that such forward-looking statements involve risks and uncertainties that could cause the Company's actual results to differ materially from those in these forward-looking statements. Such risks and uncertainties include, but are not limited to, demand for the Company's products and services, our ability to continue to develop markets, general economic conditions, our ability to secure additional financing for the Company and other factors that may be more fully described in reports to shareholders and periodic filings with the Securities and Exchange Commission.

    Contacts:                               Investors:
    Blair Barnes, CFO                       Stephanie Carrington/Amy Glynn
    Freedom2, Inc.                          The Ruth Group
    Ph: 856-354-0707 ext. 201               646-536-7017/7023
    blair@freedom2inc.com                   scarrington@theruthgroup.com
                                            aglynn@theruthgroup.com

                                            Press:
                                            Pat Arcand
                                            Arcand & Madison Public Relations
                                            Ph: 617-576-7777
                                            pat@am-pr.com


'/>"/>
SOURCE eFoodSafety.com, Inc.
Copyright©2009 PR Newswire.
All rights reserved

Related medicine news :

1. Lance Armstrong Foundation Selects Ogilvy Public Relations Worldwide to Support the LIVESTRONG Global Cancer Campaign
2. Fairview Baptist Home Selects PatientPlacement.com to Automate Referrals and Increase Patient and Resident Admissions
3. Childrens Hospital Central California Selects Turner to Manage Addition and Renovation Project
4. Yalobusha General Hospital Selects HMS to Provide Information Technology Infrastructure
5. Tomball Regional Medical Center Selects Clinical Xpert(TM) from Thomson Reuters to Lead Quality Improvement Initiatives
6. Tennessee Hospital Association Selects PivotHealth To Provide Hospital-Physician Alignment Services
7. Schering-Plough Selects Benefit Advocates for Health Advocacy
8. RPGSi Selects M2SYS Fingerprint Biometrics Software for Revolutionary Patient Identification System
9. Womans Hospital Selects rL Solutions for Improved Adverse Event and Patient Safety Reporting
10. Michigan CardioVascular Institute Selects Sage Intergy EHR to Streamline Clinical, Workflow and Reporting Efficiencies
11. Business First Selects DRE Medical Equipment as a Company of the Year
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/9/2016)... ... 2016 , ... The Pennsylvania Athletic Trainers’ Society (PATS) aired ... of 2016. The program was made possible by a Pennsylvania Department of Health ... and Human Services Administration. The broadcast, Use Your Head: Properly Managing Sport ...
(Date:12/8/2016)... ... 2016 , ... The Florida Hospital Tampa Wound Healing Institute ... (UHMS), the leading authority in hyperbaric medicine. This accreditation identifies the Institute as ... facilities have earned this distinction. This is the second time the Florida Hospital ...
(Date:12/8/2016)... (PRWEB) , ... December 08, 2016 , ... ... Donuts Franchising Company LLC, announced the first national #QuackGivesBack campaign which supported ... , “This was our first franchise-wide Quack Gives Back initiative, and ...
(Date:12/8/2016)... and JENNERSVILLE, Pa. (PRWEB) , ... December 08, ... ... that Penn Medicine Southern Chester County, a Property owned by an affiliate of ... million, 72,000 square foot Penn Medicine Southern Chester County ambulatory care center (ACC) ...
(Date:12/8/2016)... ... ... CURE Media Group, the nation’s leading digital and print media enterprise focused ... in efforts to combat lung cancer, announced CURE Media Group President Michael J. Hennessy, ... is honored to team up with Upstage Lung Cancer in order to make major ...
Breaking Medicine News(10 mins):
(Date:12/8/2016)... , Dec. 8, 2016  Pennsylvania Physician ... of Drug and Alcohol Programs Gary Tennis ... insomnia medications, known as benzodiazepines, developed with the ... "Benzodiazepines are medications that are frequently prescribed for ... they are used with opioid pain medications, benzodiazepines ...
(Date:12/8/2016)... 2016  A new study by a pair of ... opioid therapy to treat chronic pain is not only ... harmful consequences, including death. Palliative care physicians ... Mehta , M.D., authored the study which provides a ... The study was published in the December 2016 edition ...
(Date:12/8/2016)... , Dec. 8, 2016  EIP Pharma, LLC ... obtained proof-of-mechanism for neflamapimod (previously code named VX-745), ... 2a clinical trials that demonstrated significant Alzheimer,s disease ... (12-week treatment) and Study 303 (6-week treatment) are ... in Alzheimer,s Disease (CTAD) scientific conference in ...
Breaking Medicine Technology: